Advances in imaging of stargardt disease

23Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Stargardt disease (STGD1) is an autosomal-recessively inherited condition often associated with mutations in ABCA4 and characterized by accumulation of autofluorescent lipofuscin deposits in the retinal pigment epithelium (RPE). Non-invasive imaging techniques including fundus autofluorescence (FAF), spectral domain optical coherence tomography (SD-OCT) and adaptive optics scanning laser ophthalmoscopy (AOSLO) have the potential to improve understanding of vision loss in patients with STGD. We describe a comprehensive approach to the study of patients with STGD. Measures of retinal structure and FAF were correlated with visual function including best-corrected visual acuity (BCVA), color vision, kinetic and static perimetry, fundus-guided microperimetry and full-field and multifocal electroretinography. Mutation analysis of the ABCA4 gene was carried out by sequencing the complete coding region. Preliminary data suggest that a combination of imaging modalities may provide a sensitive measure of disease progression and response to experimental therapies in patients with STGD. © Springer Science+Business Media, LLC 2010.

Cite

CITATION STYLE

APA

Chen, Y., Roorda, A., & Duncan, J. L. (2010). Advances in imaging of stargardt disease. In Advances in Experimental Medicine and Biology (Vol. 664, pp. 333–340). https://doi.org/10.1007/978-1-4419-1399-9_38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free